Background: Although Remdesivir has been evaluated for the treatment of coronavirus
disease 2019 (COVID-19), few study has yet shown effective mortality reduction. It might be …

In recent years, the pandemic caused by SARS-CoV-2 has posed a significant challenge to
the entire medical community [1]. Since December 2019, the scientific community's focus …

The COVID-19 global pandemic and high mortality rates necessitate the development of
diagnostic and prognostic tools, as well as expanding testing capacity. Existing methods for …

Soil is an important source of resources required for human health and well-being. Soil is
also a major environmental reservoir of pathogenic organisms. This may include viruses like …

We investigated the electric field distribution inside a one-dimensional photonic crystal with
a defect. The field distribution in four types of defect photonic crystals was investigated …

Since the RECOVERY trial, steroids have endorsed by all Guideliness for treating moderate-
severe COVID-19. The prescribed dose is 6mg dexamethasone or its equivalents for 10 …

The resurgence of COVID-19 with the delta variant has accompanied a doubling in the
prevalence of COVID-19-associated mucormycosis (CAM) in India. The prevalence grew to …

(1) Background: C-reactive protein (CRP) and albumin are inflammatory markers. We
analyzed the prognostic capacity of serum albumin (SA) and CRP for an outcome …

A fraction of COVID-19 patients develop the most severe form, characterized by Acute
Respiratory Disease Syndrome (ARDS). The molecular mechanisms causing COVID-19 …

Anakinra, a recombinant, non-glycosylated human interleukin (IL)-1 receptor antagonist, has
been used in real-world clinical practice to manage hyperinflammation in coronavirus …